ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 272 filers reported holding ALKERMES PLC in Q2 2022. The put-call ratio across all filers is 0.80 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $53,128,668 | -15.1% | 1,896,775 | -5.2% | 0.81% | -10.2% |
| Q2 2023 | $62,600,000 | -18.5% | 2,000,000 | -26.6% | 0.91% | -18.1% |
| Q1 2023 | $76,789,560 | +1.3% | 2,724,000 | -6.1% | 1.11% | -16.3% |
| Q4 2022 | $75,777,000 | -10.5% | 2,900,000 | -23.5% | 1.32% | -10.0% |
| Q3 2022 | $84,675,000 | -2.8% | 3,792,000 | +29.7% | 1.47% | -3.4% |
| Q2 2022 | $87,106,000 | +81.5% | 2,924,000 | +60.3% | 1.52% | +63.8% |
| Q1 2022 | $47,989,000 | -35.0% | 1,824,000 | -42.5% | 0.93% | -23.1% |
| Q4 2021 | $73,781,000 | +1.5% | 3,172,000 | +34.6% | 1.21% | -1.9% |
| Q3 2021 | $72,659,000 | -24.0% | 2,356,000 | -39.6% | 1.23% | -28.1% |
| Q2 2021 | $95,628,000 | +45.3% | 3,900,000 | +10.7% | 1.71% | +13.3% |
| Q1 2021 | $65,828,000 | +48.9% | 3,524,000 | +59.0% | 1.51% | +0.5% |
| Q4 2020 | $44,209,000 | +25.6% | 2,216,000 | +4.3% | 1.50% | +17.8% |
| Q3 2020 | $35,195,000 | – | 2,124,000 | – | 1.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 2,639,676 | $96,322,000 | 7.78% |
| Meditor Group Ltd | 892,400 | $32,564,000 | 6.11% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233,000 | $8,502,000 | 3.14% |
| Tamarack Advisers, LP | 140,000 | $5,109,000 | 2.03% |
| Asymmetry Capital Management, L.P. | 27,673 | $1,010,000 | 1.69% |
| First Light Asset Management, LLC | 211,164 | $7,705,000 | 1.00% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 304,992 | $11,129,000 | 0.85% |
| Nicollet Investment Management, Inc. | 28,020 | $1,022,000 | 0.67% |
| PRIMECAP MANAGEMENT CO/CA/ | 23,263,530 | $848,886,000 | 0.62% |
| Rhenman & Partners Asset Management AB | 120,399 | $4,393,000 | 0.51% |